Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$81K Buy
1,100
+667
+154% +$50K 0.01% 505
2021
Q2
$28K Sell
433
-250
-37% -$16.7K ﹤0.01% 785
2021
Q1
$50K Buy
683
+305
+81% +$23.2K 0.01% 476
2020
Q4
$27K Sell
378
-149
-28% -$10.5K 0.01% 585
2020
Q3
$34K Buy
527
+51
+11% +$3.23K 0.01% 443
2020
Q2
$25K Buy
476
+224
+89% +$11K 0.01% 479
2020
Q1
$8K Buy
252
+6
+2% +$286 ﹤0.01% 725
2019
Q4
$12K Hold
246
﹤0.01% 674
2019
Q3
$12K Hold
246
﹤0.01% 660
2019
Q2
$11K Buy
246
+134
+120% +$6.2K ﹤0.01% 690
2019
Q1
$5K Hold
112
﹤0.01% 865
2018
Q4
$4K Buy
+112
New +$4.59K ﹤0.01% 740

Other funds holding HOLX

Berman Capital Advisors's HOLX Position: Q3 2021 in Review

Berman Capital Advisors increased its Hologic (HOLX) stake by 154% in Q3 2021, buying an estimated $50K and bringing the position to 1,100 shares worth $81K. The position accounts for 0.01% of the portfolio, ranked #505.

Berman Capital Advisors first reported a position in HOLX in Q4 2018 and has held it in 12 quarters since. 644 funds tracked by Wall St. Rank hold HOLX as of Q3 2021.

  • Berman Capital Advisors held 1,100 shares of Hologic worth $81K as of Q3 2021.
  • Berman Capital Advisors bought 667 Hologic shares in Q3 2021, an estimated $50K.
  • Hologic made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #505 holding.
  • Berman Capital Advisors first reported a position in Hologic in Q4 2018 and has held it in 12 quarters since.
  • 644 funds tracked by Wall St. Rank held Hologic as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.